LIFECORE BIOMEDICAL, INC. DE (LFCR): auditor change — Lifecore Biomedical dismisses BDO and appoints KPMG as new independent auditor

LIFECORE BIOMEDICAL, INC. DE

Audit Committee approved appointment of KPMG on August 12, 2025 as independent registered public accounting firm for transition period ending December 31, 2025.
BDO was dismissed on August 12, 2025; its audit reports for fiscal years ended May 26, 2024 and May 25, 2025 did not contain adverse opinions.
BDO's reports stated internal control material weaknesses existed as of May 26, 2024 and May 25, 2025 based on COSO criteria.
No disagreements or reportable events occurred between Lifecore and BDO during the covered periods.
Material weaknesses included deficiencies in control environment, risk assessment, and monitoring as previously disclosed in the Annual Report.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

LIFECORE BIOMEDICAL, INC. DE dismissed BDO USA, P.C. as its auditor.

Action: dismissal
Auditor: BDO USA, P.C.
Successor: KPMG LLP

Exact text from the filing

Dismissal of Independent Registered Public Accounting Firm On August 12, 2025, the Audit Committee approved the dismissal of BDO USA, P.C. (“BDO”), the Company’s current independent registered public accounting firm, and BDO was dismissed on that date. BDO’s audit reports on the Company’s consolidated financial statements as of and for the fiscal years ended May 26, 2024 and May 25, 2025 did not contain an adverse opinion or a disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting principles.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

LIFECORE BIOMEDICAL, INC. DE engaged KPMG LLP as its auditor.

Action: engagement
Auditor: KPMG LLP

Exact text from the filing

Engagement of New Independent Registered Public Accounting Firm On August 12, 2025, the Audit Committee of the Board of Directors (the “Audit Committee”) of Lifecore Biomedical (the “Company”) concluded its process to select the Company’s independent registered public accounting firm for the Company’s transition period beginning May 26, 2025 and ending December 31, 2025. Based on its review and evaluation, on August 12, 2025, the Audit Committee approved the appointment of KPMG LLP (“KPMG”) as the Company’s independent registered public accounting firm for the transition period ending December 31, 2025.

View on SEC.gov

12 auditor changes filed in the last 30 days. Browse all auditor changes →

LIFECORE BIOMEDICAL, INC. DE filing history →

Source: SEC EDGAR

accession 0001005286-25-000118

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.